Advertisement
Screener

ASTRAZENECA PLC (AZN) Form 6-K: Report of foreign private issuer, 2015

2.4 / 5 stars · 19/40 Roast Me

Add as a preferred source on Google

ASTRAZENECA PLC Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2015-12-23: Form 6-K; Period of report 2015-12-23; Description RESULT OF EXTERNAL AUDIT TENDER; Document azn201512236k1.htm.
  • 2015-12-23: Form 6-K; Period of report 2015-12-23; Description LESINURAD APPROVED BY US FDA FOR GOUT; Document azn201512236k.htm.
  • 2015-12-18: Form 6-K; Period of report 2015-12-18; Description CHMP ISSUES POSITIVE OPINION ON LESINURAD FOR GOUT; Document azn201512186k4.htm.
  • 2015-12-18: Form 6-K; Period of report 2015-12-18; Description TAGRISSO? (OSIMERTINIB) POSITIVE CHMP OPINION; Document azn201512186k3.htm.
FiledFormPeriod of reportDescriptionDocument
2015-12-236-K2015-12-23RESULT OF EXTERNAL AUDIT TENDERazn201512236k1.htm
2015-12-236-K2015-12-23LESINURAD APPROVED BY US FDA FOR GOUTazn201512236k.htm
2015-12-186-K2015-12-18CHMP ISSUES POSITIVE OPINION ON LESINURAD FOR GOUTazn201512186k4.htm
2015-12-186-K2015-12-18TAGRISSO? (OSIMERTINIB) POSITIVE CHMP OPINIONazn201512186k3.htm
2015-12-186-K2015-12-18BRILIQUE (TICAGRELOR) POSITIVE EU CHMP OPINIONazn201512186k2.htm
2015-12-186-K2015-12-17ATLANTIC TRIAL SUPPORTS CLINICAL ACTIVITYazn201512186k.htm
2015-12-176-K2015-12-17ASTRAZENECA COMPLETES ACQUISITION OF ZS PHARMAazn201512176k2.htm
2015-12-176-K2015-12-17AZ INVESTS IN ACERTA PHARMA TO ENHANCE GROWTHazn201512176k.htm
2015-12-166-K2015-12-16AZ ACQUISITION OF TAKEDA'S RESPIRATORY BUSINESSazn201512166k.htm
2015-12-156-K2015-12-15AZ COMPLETES AGREEMENT WITH PERRIGOazn201512156k.htm
2015-12-146-K2015-12-14DISCUSSIONS WITH ACERTA PHARMA BVazn201512146k.htm
2015-12-026-K2015-12-02LATE-STAGE PIPELINE CONFERENCE CALLazn201512026k.htm
2015-12-016-K2015-12-01BLOCKLISTING INTERIM REVIEWazn201512016k2.htm
2015-12-016-K2015-12-01TOTAL VOTING RIGHTSazn201512016k.htm
2015-11-236-K2015-11-23AZ ENTERS AGREEMENT W/ PERRIGO FOR ENTOCORT IN USazn201511236k.htm
2015-11-166-K2015-11-16FORM 6-Kdp61193_6k.htm
2015-11-136-K2015-11-13AZD9291 APPROVED BY THE US FDAazn201511136k.htm
2015-11-126-K2015-11-12ASTRAZENECA PRICES A $6 BILLION BOND ISSUEazn201511116k.htm
2015-11-066-K2015-11-06AZ ACQUIRES ZS PHARMA TO STRENGTHEN CVMD PORTFOLIOazn201511066k.htm
2015-11-056-K2015-11-053RD QUARTER RESULTSazn201511056k.htm
2015-11-046-K2015-11-04NOTICE OF RESULTSazn201511036k.htm
2015-11-026-K2015-11-02TOTAL VOTING RIGHTSazn201511026k.htm
2015-10-276-K2015-10-27DIRECTOR/PDMR SHAREHOLDINGazn201510276k.htm
2015-10-266-K2015-10-26FDA AD COM RECOMMENDS THE APPROVAL OF LESINURADazn201510266k.htm
2015-10-166-K2015-10-16SAXA/DAPA FDC COMPLETE RESPONSE LETTER FROM FDAazn201510166k.htm
2015-10-076-K2015-10-07ASTRAZENECA COMPLETES DIVESTMENT OF CAPRELSAazn201510076k.htm
2015-10-016-K2015-10-01TOTAL VOTING RIGHTSazn201510016k2.htm
2015-10-016-K2015-10-01DIRECTOR/PDMR SHAREHOLDINGazn201510016k.htm
2015-09-286-K2015-09-28DIRECTOR/PDMR SHAREHOLDINGazn201509286k2.htm
2015-09-286-K2015-09-28DIRECTOR/PDMR SHAREHOLDINGazn201509286k.htm
2015-09-046-K2015-09-04US FDA APPROVES EXPANDED INDICATION FOR BRILINTAazn201509046k.htm
2015-09-016-K2015-07-09TOTAL VOTING RIGHTSazn201509016k2.htm
2015-09-016-K2015-09-01ASTRAZENECA AND VALEANT TO PARTNER ON BRODALUMABazn201509016k.htm
2015-08-286-K2015-08-28DIRECTOR/PDMR SHAREHOLDINGazn201508286k.htm
2015-08-246-K2015-08-24ASTRAZENECA APPOINTS DR SEAN BOHENazn201508246k.htm
2015-08-036-K2015-08-03TOTAL VOTING RIGHTSazn201508036k.htm
2015-07-306-K2015-07-30HALF YEARLY REPORTazn201507306k.htm
2015-07-296-K2015-07-29NOTICE OF RESULTSazn201507286k.htm
2015-07-276-K2015-07-27CONFIRMATION OF CHANGE IN ADS RATIOazn201507276k2.htm
2015-07-276-K2015-07-27ASTRAZENECA AGREEMENT WITH GENZYME ON CAPRELSAazn201507276k.htm
2015-07-176-K2015-07-17HOLDING(S) IN COMPANYazn201507176k2.htm
2015-07-176-K2015-07-17AZ COMPLETES AGREEMENT WITH TILLOTTS FOR ENTOCORTazn201507176k.htm
2015-07-146-K2015-07-14IRESSA APPROVED BY US FDAazn201507146k.htm
2015-07-096-K2015-07-09AGREEMENT WITH TILLOTTS ON ENTOCORTazn201507086k.htm
2015-07-016-K2015-07-01TOTAL VOTING RIGHTSazn201507016k.htm
2015-06-266-K2015-06-26CHANGE IN ADS RATIOazn201506266k.htm
2015-06-256-K2015-06-25PUBLICATION OF PROSPECTUSazn201506256k.htm
2015-06-166-K2015-06-16DIRECTOR/PDMR SHAREHOLDINGazn201506166k.htm
2015-06-036-K2015-06-03HOLDING(S) IN COMPANYazn201506036k.htm
2015-06-016-K2015-06-01ASTRAZENECA PLC - BLOCKLISTING INTERIM REVIEWazn201506016k1.htm
2015-06-016-K2015-06-01TOTAL VOTING RIGHTSazn201506016k.htm
2015-05-266-K2015-05-26UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMMEazn201505266k.htm
2015-05-136-K2015-05-13HOLDING(S) IN COMPANYazn201505136k.htm
2015-05-086-K2015-05-08DIRECTOR/PDMR SHAREHOLDINGazn201505086k2.htm
2015-05-086-K2015-05-08DIRECTOR/PDMR SHAREHOLDINGazn201505086k.htm
2015-05-076-K2015-05-07DIRECTOR DECLARATIONazn201505076k.htm
2015-05-016-K2015-05-01DIRECTOR/PDMR SHAREHOLDINGazn201505016k.htm
2015-05-016-K2015-05-01TOTAL VOTING RIGHTSazn201505016k1.htm
2015-04-296-K2015-04-24DIRECTOR/PDMR SHAREHOLDINGazn201504296k.htm
2015-04-246-K2015-04-24RESULT OF AGMazn201504246k3.htm
2015-04-246-K2015-04-241ST QUARTER RESULTSazn201504246k2.htm
2015-04-246-K2015-04-24COLLABORATION WITH CELGENE ON PD-L1 IN HAEMATOLOGYazn201504246k1.htm
2015-04-246-K2015-04-24AZ AND INNATE TO COLLABORATE IN IMMUNO-ONCOLOGYazn201504246k.htm
2015-04-236-K2015-04-23NOTICE OF RESULTSazn201504236k.htm
2015-04-176-K2015-04-17SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION BY FDAazn201504176k.htm
2015-04-156-K2015-04-15FDA REVIEWS SAVOR OUTCOMES STUDY RESULTSazn201504156k1.htm
2015-04-156-K2015-04-15TREMELIMUMAB GRANTED ORPHAN DRUG DESIGNATIONazn201504156k.htm
2015-04-016-K2015-04-01TOTAL VOTING RIGHTSazn201504016k.htm
2015-03-306-K2015-03-30DIRECTOR/PDMR SHAREHOLDINGazn201503306k.htm
2015-03-196-K2015-03-19FORM 6-Kd891714d6k.htm
2015-03-196-K2015-03-19COLLABORATION WITH DAIICHI SANKYO INCazn201503196k1.htm
2015-03-196-K2015-03-19NOTICE OF AGMazn201503196k.htm
2015-03-186-K2015-03-18POSITIVE PHASE III RESULTS FOR PT003 IN COPDazn201503186k.htm
2015-03-166-K2015-03-16BRILINTA PEGASUS-TIMI 54 STUDYazn201503166k.htm
2015-03-106-K2015-03-10FILING OF FORM 20-F WITH SECazn201503106k1.htm
2015-03-106-K2015-03-10ANNUAL FINANCIAL REPORTazn201503106k.htm
2015-03-066-K2015-03-06ASTRAZENECA REFINES ITS FINANCIAL REPORTINGazn201503066k.htm
2015-03-046-K2015-03-04AZ TO PARTICIPATE IN US FDA EMDACazn201503046k.htm
2015-03-036-K2015-03-03ACQUISITION OF RIGHTS TO ACTAVIS' PORTFOLIOazn201503036k.htm
2015-03-026-K2015-03-02TOTAL VOTING RIGHTSazn201503026k.htm
2015-02-176-K2015-02-17DIRECTORATE CHANGEazn201502176k.htm
2015-02-176-K2015-02-16PULMICORT RESPULES? US PATENT LITIGATION DECISIONazn201502166k.htm
2015-02-056-K2015-02-05AZ TO ACQUIRE ACTAVIS? US RESPIRATORY PORTFOLIOazn201502056k2.htm
2015-02-056-K2015-02-05FINAL RESULTSazn201502056k.htm
2015-02-046-K2015-02-04NOTICE OF RESULTSazn201502046k.htm
2015-02-026-K2015-02-02TOTAL VOTING RIGHTSazn201502026k.htm
2015-01-226-K2015-01-22MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMAazn201501226k.htm
2015-01-146-K2015-01-14BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINTazn201501146k.htm
2015-01-026-K2015-01-02TOTAL VOTING RIGHTSazn201501026k.htm
Advertisement